Zenaro

Quick links to important sections

Zenaro

Selected form

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zenaro

Zenaro is a synthetic medicinal product whose active ingredient is Levocetirizine Dihydrochloride, formally classified as an antihistamine used for managing allergic conditions. It is specifically a second-generation H1-receptor antagonist, clinically recognized for providing sustained relief from common allergy symptoms.

Property Description
Active Ingredient Levocetirizine Dihydrochloride
Form Film-coated tablets, Oral solution
Pharmacological Class Second-Generation H1-Receptor Antagonist
Common Purpose Mitigation of general allergic symptoms
Origin Synthetic compound

Defining Zenaro: A Second-Generation Antihistamine

Zenaro is fundamentally identified by its class: it is a second-generation H1-receptor antagonist. This distinction is important because the drug is designed to act selectively on the histamine receptors located outside the brain, providing therapeutic relief. The compound is an orally active H1-receptor antagonist. Zenaro is often positioned as an option for patients seeking control over seasonal allergic symptoms, such as those experienced during peak pollen seasons.

Composition and Origin: The Active R-Enantiomer

The medicine is a single-ingredient product, containing only Levocetirizine as the compound responsible for the anti-allergic effect. Chemically, Levocetirizine is a synthetic compound isolated as the pure R-enantiomer of the related substance, Cetirizine. This isolation makes it a more direct form of the active component. Zenaro is available for oral route of administration in standard film-coated tablets and an oral solution, offering patients a choice of convenient physical forms.

Purpose and High-Level Action

The overall purpose of Zenaro is the effective mitigation of allergic symptoms. This anti-allergic effect is achieved by Levocetirizine competitively binding to the H1 receptors on cell surfaces. By preventing the natural compound histamine from attaching to these receptors, the drug interrupts the allergic response cascade. Pharmacological studies consistently demonstrate that this targeted mechanism provides reliable symptom management by preventing the cellular processes that lead to irritation, itching, and swelling associated with allergies.

What side effects are possible with Zenaro?

Possible Side Effects and Safety Information

The safety profile for Zenaro (Levocetirizine) is formally documented in government regulatory sources, classifying adverse reactions by frequency and the body system affected. These classifications structure the understanding of the medicine’s risks.


Frequency-Classified Adverse Reactions

The most commonly documented adverse reactions, generally observed in clinical trials at an incidence rate of 2% or greater and more frequently than placebo in adults and adolescents, include somnolence (drowsiness), fatigue, dry mouth, nasopharyngitis, and pharyngitis. Reactions reported in the postmarketing setting, where the frequency cannot be reliably determined, include palpitations, tachycardia (rapid heart rate), and urinary retention

.

Adverse reactions are grouped into official System-Organ Classes (SOCs), such as Nervous System Disorders (e.g., somnolence, headache) and Gastrointestinal Disorders (e.g., dry mouth, diarrhea).


Serious Safety Considerations and Constraints

The medicine is contraindicated in patients with a known history of hypersensitivity reactions to levocetirizine or its parent compound, cetirizine. It is also contraindicated in individuals diagnosed with End-Stage Renal Disease (ESRD), specifically defined as a creatinine clearance of less than 10 mL/min.

Safety notes advise caution regarding the performance of activities requiring complete mental alertness, such as operating hazardous machinery or driving, due to the potential for somnolence and fatigue. Caution is also noted for patients with factors predisposing to urinary retention, such as prostatic hyperplasia.

Time-related safety patterns have been observed, including reports of severe pruritus (itching) occurring after the cessation of daily, long-term use.

Overdose and Emergency Response

Overdose and When to Seek Help

This section describes the officially documented clinical manifestations of overdose for Zenaro (Levocetirizine) and the emergency actions mandated by regulatory authorities.

Documented Overdose Manifestations

Population Official Regulatory Description
Adults The primary clinical sign documented in cases of overdose is drowsiness (somnolence).
Pediatric Patients Overdose in children may first involve agitation and restlessness as initial signs, which are subsequently followed by the onset of drowsiness.

Emergency Actions and Management

Regulatory authorities require that emergency services (such as the Poison Help line or 911) be contacted immediately if a severe, life-threatening clinical state is observed following a suspected overdose. This includes official triggers such as the individual having collapsed, experiencing a seizure, exhibiting trouble breathing, or being unable to be awakened.

Supportive Treatment Constraints

The regulatory profile explicitly states that there is no known specific antidote for Levocetirizine dihydrochloride documented in official prescribing information. Consequently, the recommended management approach is confined to symptomatic or supportive treatment.

An important procedural constraint is noted: the active compound is not effectively removed by dialysis, a consideration that limits its utility in overdose management unless other dialyzable agents were simultaneously ingested.

Therapeutic Uses of Zenaro

What Zenaro treats: main uses and benefits

Zenaro is a pharmacological treatment containing the active substance levocetirizine dihydrochloride. It belongs to a class of medications known as antihistamines, which work by blocking the effects of histamine—a natural substance in the body that triggers allergic reactions.

Main Therapeutic Uses

This medication is primarily used to manage symptoms associated with various allergic conditions in adults and children. These include:

  • Allergic Rhinitis: Zenaro is used to treat symptoms associated with inflammation of the nasal passages caused by allergens. This includes both seasonal allergic rhinitis (such as hay fever) and perennial allergic rhinitis (which occurs year-round due to triggers like dust mites or pet dander).
  • Chronic Idiopathic Urticaria: It is also used to treat the symptoms of chronic hives, a condition characterized by the persistent appearance of itchy red bumps or welts on the skin without a clearly identifiable cause.

Benefits and Symptom Relief

By inhibiting the H1 histamine receptors, Zenaro helps alleviate the physical manifestations of an allergic response. Patients using this medication typically seek relief from the following symptoms:

  • Nasal Symptoms: Reduction in sneezing, runny nose, and nasal congestion or itching.
  • Ocular Symptoms: Improvement in itchy, red, or watery eyes associated with hay fever or other airborne allergens.
  • Dermatological Symptoms: Reduction in the itching, redness, and swelling (wheals) associated with chronic hives.

As a later-generation antihistamine, the active ingredient in Zenaro is designed to provide effective relief from these symptoms. Its primary benefit is the restoration of daily comfort by minimizing the physical discomfort and irritation caused by the body’s overreaction to common environmental triggers.

Eligibility and Restrictions for Use

Zenaro (levocetirizine) eligibility is determined by official regulatory criteria regarding patient age, physiological condition, and known allergies.

Populations for Whom Use is Contraindicated

Zenaro is formally contraindicated in the following groups, as stated in prescribing information:

  • Patients with known hypersensitivity to levocetirizine, cetirizine, hydroxyzine, or any other piperazine derivative.
  • Patients with End-Stage Renal Disease (ESRD), defined as a creatinine clearance (CLCR) less than 10 mL/min, or those undergoing hemodialysis.
  • Pediatric patients aged 6 months to 11 years with impaired renal function.

Age-Related Eligibility Rules

Age Group Eligibility Status
Children Approved for those mathbf6 months of age and older (using appropriate formulation).
Infants Safety and efficacy have not been established for children younger than mathbf6 months old.
Adults & Adolescents Approved for individuals mathbf12 years of age and older.

Condition-Specific Restrictions

Use is restricted or requires caution in several patient groups:

  • Patients mathbf12 years or older with mathbfmild to severe renal impairment must have their use conditional upon a dose adjustment.
  • Use requires caution in patients with predisposing factors for urinary retention (e.g., prostatic hyperplasia).
  • Use during mathbfbreastfeeding is generally not recommended.
  • Patients with solely hepatic impairment do not require a dose adjustment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Zenaro (Levocetirizine) has officially documented interaction patterns that primarily relate to additive central nervous system (CNS) effects and modifications to the drug’s clearance.

Pharmacodynamic Interactions

Co-administration with alcohol and other Central Nervous System (CNS) depressants must be avoided. Regulatory documents state that this combination may cause an additional reduction in alertness and further impairment of CNS performance. This effect is based on pharmacodynamic reinforcement.

Pharmacokinetic and Exposure Alterations

Studies with the active racemate, Cetirizine, indicate that co-administration with Ritonavir resulted in a decrease in clearance (approximately 42% reduction) and an increase in the Area Under the Curve (AUC) (approximately 32% increase) of the racemate. The drug's metabolism via the CYP enzyme system is minimal, according to official labeling.

Administration Constraints and Procedural Interference

  • Food: Taking Zenaro with food does not change the total extent of absorption but does lead to a decreased rate of absorption.
  • Allergy Skin Tests: Levocetirizine must be discontinued for a period (typically three days) before undergoing allergy skin tests to prevent interference with the accuracy of the test results.

Population-Specific Considerations

The risk of adverse reactions, including potential interaction-related issues, may be greater for patients with impaired renal function. This caution is noted because levocetirizine is substantially excreted by the kidneys.

Mechanism of Action

H1 Receptor Inverse Agonism: Modulation of Acute H1 R Signaling

Levocetirizine operates as a highly selective and high-affinity inverse agonist at the peripheral Histamine H1 Receptor ( H1R) . This mechanism stabilizes the H1R in an inactive conformation, actively reducing its constitutive activity and preventing the binding of histamine. This primary blockade modifies the early molecular steps that shape systemic physiological outcomes, directly limiting H1 R-driven increases in vascular permeability and suppressing the activation of sensory nerves.

Non- H1 Modulation of Inflammatory Cell Recruitment

Beyond the H1R blockade, the drug engages mechanisms that influence downstream physiological processes. It exerts a non- H1-mediated effect by influencing the movement of key immune cells, specifically inhibiting the migration and adhesion of eosinophils into target tissues. This modulation of the inflammatory cell recruitment pathway influences the physiological response in later phases of inflammation and results in the modulation of excessive mediator activity on the body.

Dosage and Administration Information

How to use Zenaro — Official Administration Guidelines

Zenaro (levocetirizine dihydrochloride) is an antihistamine administered orally once daily. The official instructions for use emphasize adherence to the prescribed daily dose and timing, which is necessary for the medication to work effectively.

Administration Details

Detail Instruction
Route Oral (Tablet or Oral Solution)
Frequency Once daily
Timing Administer in the evening.
Food Intake Can be taken without regard to food consumption.

Official Dosing Rules by Age Group

The maximum recommended dose varies by age group and is not to be exceeded. The dose for patients 12 years and older may be reduced for less severe symptoms.

Age Group Recommended Daily Dose Maximum Daily Dose Dosage Form
Adults & Children geq 12 yrs 5 mg 5 mg Tablet or Oral Solution (10 mL)
Children 6–11 yrs 2.5 mg 2.5 mg frac12 Tablet or Oral Solution (5 mL)
Children 6 mos–5 yrs 1.25 mg 1.25 mg Oral Solution (2.5 mL)

Procedural Steps and Missed Dose

If you are using the tablet form and a 2.5 mg dose is recommended, the 5 mg scored tablet may be broken in half. The oral solution must be measured using an appropriate measuring device for accuracy. The tablet should be swallowed whole or broken as directed, but not crushed or chewed beyond halving. If a dose is missed, take it as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped to prevent taking a double dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Zenaro


Evidence for Use in Perennial Allergic Rhinitis (Year-Round Allergy Symptoms)

Research has explored how Zenaro was studied for perennial allergic rhinitis. The research explored how symptoms associated with this condition were measured. The primary research for this indication often involved short-term randomized, placebo-controlled clinical trials (RCTs). These studies monitored outcomes related to physical discomfort by measuring Total Symptom Scores (TSS) and patient-reported measures of daily functioning (Health-Related Quality of Life, or HRQL).

Findings described patterns observed in the studies where the measured symptom scores were reported as differing from the scores observed in the control groups receiving an inactive substance (placebo). Research highlights changes measured during the study period and provides context regarding the patterns of symptoms observed in the studied populations.


Evidence for Use in Seasonal Allergic Rhinitis (Seasonal Allergy Symptoms)

Zenaro was evaluated in research that explored seasonal allergic rhinitis, which are conditions involving periods of heightened symptoms usually triggered by seasonal factors. These studies often used similar short-term randomized, controlled trial designs. Researchers primarily measured changes in total nasal and non-nasal symptom scores and sometimes studies monitored changes in objective measures, such as Nasal Airflow.

Short-term trials reported that studies suggest differences in symptom scores when compared to the control groups. Evidence is limited in providing context for how symptoms may change from one year to the next, as follow-up durations were typically limited to a few weeks. The research exploring physical markers, such as inflammatory biomarkers, often was observed in some studies that had sample sizes were modest.


What is Still Uncertain About Zenaro Research

A primary limitation is that there is limited information for long-term outcomes across all indications, meaning the research provides context but not individual predictions about symptom patterns over many years. Comparative evidence is lacking for certain new or alternative treatment options. Data for certain groups remain insufficient, including for pregnant individuals or patients with certain comorbid conditions, which are areas of ongoing research.

Frequently Asked Questions (FAQ)

Common questions about Zenaro (FAQ)


Q: How quickly should someone expect Zenaro to start working?

The active ingredient in Zenaro is reported to be rapidly absorbed following oral administration. Official regulatory documents indicate that the peak concentration of the drug is typically reached in the bloodstream in less than an hour.


Q: How long do the effects of Zenaro usually last?

The drug's administration is consistent with a once-daily schedule, which reflects its long duration of action. Official clinical pharmacology information indicates that the average elimination half-life—the time it takes for half the drug to be removed from the body—is approximately 7 to 10 hours in adults.


Q: Is Zenaro known to be safe for older adults?

Official prescribing information notes that patients 65 years of age and older are advised to discuss use with a healthcare provider. This discussion is necessary because adjustments to the dose may be required based on the individual's kidney function.


Q: Does Zenaro interact with pain relievers like ibuprofen or acetaminophen?

Regulatory labeling highlights interactions with alcohol and CNS depressants. Specific clinical pharmacokinetic studies detailing interactions between levocetirizine and common pain relievers like ibuprofen or acetaminophen are generally not detailed in the official product information.


Q: Does Zenaro have any known impact on blood pressure?

Postmarketing experience with the drug has included rare reports of changes in blood pressure. These adverse reactions have included reports of both low blood pressure (hypotension) and high blood pressure (hypertension).


Q: Is there a generic version of Zenaro available?

Yes, the active ingredient in Zenaro, levocetirizine dihydrochloride, is widely available in generic formulations. These generic versions are available as both oral tablets and oral solutions.


Q: Does Zenaro contain gluten or any common allergens?

Official product labeling identifies the active ingredient and lists all inactive ingredients (excipients). Patients concerned about non-active components may wish to review the complete ingredient list provided in the package.


Q: What kind of interactions does Zenaro have with herbal supplements?

Official warnings advise reporting all herbal products or nutritional supplements to a healthcare provider before starting levocetirizine. This allows them to assess the potential for any unwanted interactions.


Q: Does Zenaro require a prescription, or is it available over-the-counter?

The active ingredient, levocetirizine dihydrochloride, is available for purchase without a prescription (over-the-counter). It is commonly used for the temporary relief of general allergy symptoms.


Q: Is there a link between Zenaro and mood changes?

Postmarketing experience includes reports of several neurological adverse reactions. These include reports of mood-related changes such as aggression, agitation, and depression.


Q: Can Zenaro be taken with acid reflux medication?

Regulatory documents do not typically specify routine dose adjustments when taking Zenaro with most common antacid agents or acid reflux medications. There are generally no known specific pharmacokinetic interactions noted in official labeling for these combinations.


Q: Does Zenaro have any known weight-related side effects?

Postmarketing experience has included reports of adverse reactions that may affect weight. These have been associated with both an increased appetite and resulting weight gain.


Q: What happens if someone accidentally takes too much Zenaro?

In the event that someone takes too much Zenaro, regulatory documents state that symptomatic or supportive treatment is recommended. The typical initial sign in adults is often pronounced drowsiness, while children may first experience agitation or restlessness.


Q: Is it okay to take Zenaro if someone is also taking vitamins?

Official warnings advise that a healthcare professional should be informed of any vitamins or other nutritional supplements being taken. This precautionary step allows a healthcare provider to assess potential interaction risk.


Q: Why is Zenaro not recommended for people with glaucoma?

Official caution is advised for patients with certain predisposing factors, such as narrow-angle glaucoma. This is noted because antihistamines as a class may exhibit anticholinergic effects, which can potentially affect conditions like glaucoma or those related to urinary retention.


Q: Is Zenaro considered to be a strong medicine?

Zenaro is officially described as a highly selective and high-affinity inverse agonist that acts on the histamine receptors. This targeted mechanism reduces the receptor's activity and is recognized as a drug that provides symptom relief.


Q: Are there any common foods or drinks that should be avoided when using Zenaro?

Regulatory instructions emphasize that co-administration with alcohol is advised to be avoided due to the potential for further impairment of alertness. Regarding food, official information indicates that taking the medication with food does not change the total amount absorbed, but it may lead to a slower rate of absorption.


Q: What is the difference between Zenaro and other similar over-the-counter allergy pills?

Zenaro is classified in regulatory documents as a second-generation H1-receptor antagonist. Chemically, it is a single-ingredient product isolated as the pure R-enantiomer of a related compound, which is a distinction sometimes used to describe its targeted action.


Q: Why do some people report feeling dizzy after taking Zenaro?

While dizziness itself is not always officially listed, common adverse reactions documented in regulatory sources include somnolence (drowsiness) and fatigue. These known effects can sometimes contribute to feelings of unsteadiness or dizziness.


Q: Is Zenaro safe for long-term use?

Research evidence indicates that there is limited information for long-term outcomes across all indications of Zenaro use. Additionally, postmarketing experience includes reports of severe itching, known as pruritus, occurring after the cessation of daily, long-term use.


Q: Are there specific symptoms that mean someone should stop taking Zenaro immediately?

Zenaro is formally contraindicated in patients with a known history of hypersensitivity reactions to the drug or related compounds. Any patient experiencing signs of an allergic reaction should seek immediate medical assistance.


Q: Is Zenaro known to cause dry mouth or dry eyes?

Dry mouth is listed in regulatory sources as one of the most common adverse reactions reported in clinical trials. However, documentation of dry eyes is not consistently or formally reported in the drug's official labeling.


Q: Does Zenaro have different effects depending on the time of day it is taken?

Official administration guidelines recommend taking Zenaro in the evening. This timing is generally advised because the drug has the potential to cause somnolence (drowsiness) and fatigue, which could impact daily activities if taken earlier.


Q: Is it normal to feel a mild headache when first starting Zenaro?

Headache is an adverse reaction formally documented under the nervous system disorders classification. The official documentation does not, however, provide specific information on whether this effect is more common or frequent when first starting the medication.


Q: Can Zenaro be used by people with a history of heart issues?

Postmarketing reports of adverse reactions include cardiac issues such as palpitations and tachycardia (rapid heart rate). This safety information is typically reviewed by healthcare providers when determining the appropriateness of the drug for patients with a history of heart conditions.


Q: What is the mechanism of action of Zenaro in simple terms?

Zenaro is a type of medicine that works by acting as a highly selective antagonist at the peripheral Histamine H1 Receptor. In simple terms, this means it blocks the activity of histamine—the natural compound responsible for allergic reactions—thereby helping to stop the allergic response cascade.

How should Zenaro be stored and disposed of?

How to Store and Dispose of Zenaro?

The official storage and disposal requirements for Zenaro (Levocetirizine Dihydrochloride) are set by regulatory authorities to maintain the product's stability and ensure public safety.

Zenaro film-coated tablets require storage at a Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F). The medication must be protected from excess heat and moisture and should remain in its tightly closed, original container.

Storage Requirement Rule
Temperature Store between 20 C and 25 C
Environmental Protect from excess heat and moisture
Container Keep in the original, tightly closed container

Crucially, all containers must be placed in a safe location, out of the sight and reach of children.

Disposal of any unused or expired product must be done strictly in accordance with local requirements. Official instructions prohibit throwing Zenaro into the household trash or flushing it down a toilet or sink to prevent release into the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zenaro found in:

A-Z Index: